Total planned funding: $692,833,570
Clear active filters
University
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Mozambique | $171,041,114 |
| Kenya | $115,475,311 |
| Tanzania | $79,111,038 |
| Zambia | $50,754,000 |
| Ethiopia | $32,575,265 |
| Uganda | $30,734,222 |
| South Africa | $27,078,198 |
| Botswana | $23,175,232 |
| Democratic Republic of the Congo | $18,782,148 |
| Malawi | $17,210,623 |
| Côte d'Ivoire | $15,703,560 |
| Namibia | $15,226,600 |
| Eswatini | $15,017,542 |
| Haiti | $11,174,404 |
| Nigeria | $9,336,178 |
| South Sudan | $8,729,752 |
| Angola | $7,695,372 |
| Lesotho | $6,708,710 |
| Central Asia Region | $6,560,092 |
| Caribbean Region | $6,415,200 |
| Central America Region | $5,875,235 |
| Rwanda | $3,432,569 |
| Vietnam | $2,968,321 |
| Ukraine | $2,800,000 |
| Burma | $2,800,000 |
| Zimbabwe | $1,823,000 |
| Cameroon | $1,579,884 |
| Burundi | $1,400,000 |
| Ghana | $700,000 |
| India | $600,000 |
| Dominican Republic | $350,000 |
Organizational Types
| University | $692,833,570 |
Program Areas
| Treatment | $271,963,222 |
| Prevention | $147,223,866 |
| Care | $107,396,979 |
| Governance and Systems | $94,078,262 |
| Testing | $72,171,241 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $244,404,965 |
| HVCT: Testing: HIV Testing and Counseling | $72,171,241 |
| HVSI: Strategic Information | $57,686,473 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $55,826,854 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $49,291,130 |
| HBHC: Care: Adult Care and Support | $48,311,536 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $31,466,892 |
| PDTX: Treatment: Pediatric Treatment | $26,998,257 |
| OHSS: Health Systems Strengthening | $25,751,458 |
| HVTB: Care: TB/HIV | $23,413,629 |
| HKID: Care: Orphans and Vulnerable Children | $21,827,018 |
| PDCS: Care: Pediatric Care and Support | $13,844,796 |
| HLAB: Laboratory Infrastructure | $10,640,331 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,539,689 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $4,207,637 |
| HMBL: Biomedical Prevention: Blood Safety | $1,009,570 |
| HMIN: Biomedical Prevention: Injection Safety | $882,094 |
| HTXD: Treatment: ARV Drugs | $560,000 |
Top Partner Programs
Johns Hopkins University:
$157,909,642
View countries